ロード中...
Bicyclic Boronates as Potent Inhibitors of AmpC, the Class C β-Lactamase from Escherichia coli
Resistance to β-lactam antibacterials, importantly via production of β-lactamases, threatens their widespread use. Bicyclic boronates show promise as clinically useful, dual-action inhibitors of both serine- (SBL) and metallo- (MBL) β-lactamases. In combination with cefepime, the bicyclic boronate t...
保存先:
| 出版年: | Biomolecules |
|---|---|
| 主要な著者: | , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2020
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7356297/ https://ncbi.nlm.nih.gov/pubmed/32545682 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/biom10060899 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|